phd in pharmacy salary in us

Jobs for Pharm.D. vs. Ph.D. — What’s the Difference?

Written by Kelly Jeroski

April 20, 2023

Here’s something you might not know about pharmacists — pharmaceutical professionals can choose to focus their career on either patient care or research. In fact, there’s a different degree for each path.

A Doctor of Pharmacy (Pharm.D.) prepares students to become Pharmacists focused on patient care, while a Doctor of Philosophy (Ph.D.) prepares students for careers in academia or research and development.

Both patient-care and research positions within pharmacy are similar in that students receive formal training and education in common subjects such as drug development, drug delivery, and medicine chemistry, but their career paths and opportunities differ in several ways.

Let’s talk about the difference between patient-care and research within the field of pharmacy.

The Patient-Care Track vs. the Research Track

The Pharm.D. track is a four-year program — ending with Advanced Pharmacy Practice Experience (APPE) rotations and two personal and professional development courses. Once patient-care focused pharmacists enter the workforce, job opportunities after Pharm.D. focus on an individual’s treatment options when it comes to prescription pharmaceuticals. Pharmacists typically work as providers at pharmacies or hospitals throughout their career, and it is possible to advance into management positions.

The research track of pharmacology (Ph.D.) on the other hand, often extends beyond four years and ends in an extensive research project. Pharmacology researchers, generally, work on molecular targeting, drug design, and drug delivery in developing new approaches to treat disease. Research professionals may operate as researchers at universities, hospitals, private corporations, or laboratories. Many choose to work as professors within universities in addition to research work, but they do not serve as health care providers.

How to Become a Pharmacist — Types of Pharmacy Degrees

Doctor of pharmacy.

The Doctor of Pharmacy (Pharm.D.) includes a mix of classroom instruction and real-world experience to provide students with the skills to excel in pharmacy. The school targets active learning in at least 30 percent of each student's educational track. This cooperative learning model ensures that graduates have the communication skills and practical experiences to pass licensing exams and achieve pharmacist career path.

What Do Pharmacists Learn?

The program works closely with the College of Medicine to foster a team-oriented approach to pharmacy and medicine. The College of Pharmacy has two departments: pharmaceutical sciences and pharmacy practice.

Ph.D. Programs

Students interested in research have a number of opportunities related to biomedical sciences. Graduate students receive a mix of classroom instruction and real-world research experience by working alongside faculty.

Pharmacology is the research side of the Pharm.D. program. Students in this area may develop expertise in molecular targeting, drug design, and drug delivery in specific response to disease. The program uses a combination of classroom instruction, laboratory work, and the opportunity to work alongside faculty at NEOMED and Kent State University. Prior to starting a Ph.D. program, most students will need to earn a master’s degree after their four-year degree. Some programs may integrate the master’s and Ph.D. degrees where one builds upon the other.

Comparing the Job Markets for Pharm.D. vs. Ph.D.

Pharmacists.

In 2019, the median pharmacist salary was $128,090. For pharmacists, the number of hospital jobs is expected to grow by 4 percent by 2028. Pharmacists take prescriptions from medical doctors and administer medications to patients. They are also qualified to ask questions and provide information regarding the medicines they prescribe. The majority of pharmacists work in pharmacies within retail stores or medical facilities although the field is evolving with more and more recent graduates electing to work in clinical settings. There are even niche sectors of medicine different types of pharmacists can specialize in with a year or two of residency after graduation. 

Working as a pharmacist requires a Doctor of Pharmacy, known as a Pharm.D., which is a four-year degree. They are also required to pass two exams related to licenses.

Medical Researchers

Medical researchers (M.S. and Ph.D.) earned a median annual salary of $88,790 in 2019, and the field is expected to grow by 6 percent, which is a bit faster than the national average. Most researchers work full time in either a laboratory or a general office environment. These positions are responsible for the study of medical conditions and the development of treatments and medicines.

Working in this field usually requires a Ph.D., but many candidates are able to obtain rewarding positions based on experience or other academic accomplishments. For example, some medical researchers also have a medical degree in addition to a medical research background.

Jumpstart Your Health Care Career at NEOMED — Connect With Us!

Take the next step toward an exciting career in the medical field — we can help you get started.

If you need help deciding which of the above career paths is best for you, we invite you to schedule a career consultation with us. In order to do so, contact the College of Pharmacy at [email protected] or schedule a meeting . Best of luck!

Want to learn more about health care careers after NEOMED? Download our resource, "Getting a Job as a Medical Professional with Your Health Care Degree".

About the author

Kelly jeroski.

Assistant Director of Admission

More Articles

What can you do with a pharmacy degree, what do you learn in pharmacy school here are 6 surprising things, 4 tips for your pharmacy school interview.

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• Am J Pharm Educ
• v.75(1); 2011 Feb 10

Economic Analysis of Earning a PhD Degree After Completion of a PharmD Degree

To determine the net present value (NPV) and internal rate of return (IRR) for earning a doctor of philosophy (PhD) degree and pursuing careers commonly associated with that degree after completion of a doctor of pharmacy (PharmD) degree compared to entering pharmacy practice directly upon completion of the PharmD degree.

Income profiles were constructed based on 2008 annual salary data. NPV and IRR were calculated for careers resulting from the PhD degree and compared to those of the practicing community pharmacist. Trends in IRR also were examined across career paths from 1982 to 2008. A priori assumptions were developed and sensitivity analyses were conducted.

The NPVs for all careers associated with the PhD degree were negative compared to that of the practicing community pharmacist. IRRs ranged from -1.4% to 1.3% for PhD careers. Longitudinal examination of IRRs indicated a negative trend from 1982 to 2008.

Conclusions

Economic financial incentives for PharmD graduates to pursue graduate school are lacking. The study illustrates the need to consider financial incentives when developing recruitment methods for PharmD graduates to pharmacy graduate programs.

INTRODUCTION

Pharmacy school graduates are presented with many career and postgraduate educational options once the doctor of pharmacy (PharmD) degree is earned. Attending graduate school to obtain a degree in a pharmacy-related area is an option chosen by few pharmacy school graduates. Only 9.8% of graduate students enrolled in pharmacy PhD programs have earned a United States (US) pharmacy degree. 1 This percentage has steadily decreased over the last 4 decades. 2 - 4 There also has been a downward trend in enrollment of foreign students holding pharmacy degrees into US graduate school programs in pharmacy. Pharmacy educators have hypothesized that financial incentives in practice, the transition to a more clinical focus in pharmacy curricula, and implementation of the 6-year PharmD as the entry-level pharmacy degree have led to the downward trend in graduate school enrollment by US pharmacy graduates. 5 - 7 Concern has been raised regarding the lack of faculty in US colleges and schools of pharmacy who have earned US pharmacy degrees and pursued graduate education. 5 , 8 - 13 To encourage pharmacy graduates to enter graduate school, researchers have suggested colleges and schools use such interventions as stressing scientific inquiry, utilizing marketing models, mentoring students, promoting flexibility within pharmacy curricula, and providing competitive stipends to graduate students. 8 , 14 - 22

Completion of graduate education constitutes an investment. The pharmacy school graduate who chooses to invest in graduate education must forego considerable financial incentives associated with entering pharmacy practice directly. The pharmacy profession is one in which new college graduates can earn an average starting salary in excess of $100,000. This salary presents significant opportunity cost to the student interested in graduate study. Moreover, completion of a PhD in a pharmacy-related area and employment in academia or industry are often associated with starting salaries $20,000 less than those of newly licensed community pharmacists. 23 Regarding graduate education, the question becomes, “Is the investment worth it?”

Considering the relatively lower starting salaries, continued increase in number of colleges and schools of pharmacy, and demand for pharmacists in practice settings, the US shortage of 425 faculty members is not surprising. 24 Pharmacy graduates with residency and/or fellowship training have filled positions in academic settings as the profession has developed an increasingly clinical orientation. Thus, the need for PhD graduates who are pharmacists can be questioned. A comparison of residencies, fellowships, and graduate programs, however, reveals distinct objectives for each of the post-PharmD educational options. In the last 30 years, pharmacy educators have stressed the need for faculty members with PhD training and the skills learned therein to advance the profession. 10 , 15 , 25

Given the financial opportunity cost and time associated with pursuing a graduate degree, why then would anyone with a US pharmacy degree consider pursuing graduate school? There are 2 hypotheses that justify pursuing graduate school: (1) there are long-term financial incentives associated with obtaining a PhD and/or (2) pharmacy school graduates are motivated to pursue the PhD degree by non-financial motivational beliefs. Research regarding the long-term financial outlook of careers commonly pursued by PhD graduates is lacking. Financial data collected by the American Association of Colleges of Pharmacy (AACP) and the American Association of Pharmaceutical Scientists (AAPS) indicate that the mean starting salary for PhD-trained pharmacy faculty members is indeed less than the mean starting salary for practicing community pharmacists. 26 , 27 The comparison of faculty and community practitioner salaries is confounded by many pharmacy faculty members and graduate students enrolled in pharmacy graduate programs not having a US pharmacy degree. Faculty members and graduate students with non-pharmacy backgrounds would not be able to practice as pharmacists; therefore, their earning potential can not be compared directly to the salaries of practicing pharmacists. If the pharmacy profession wishes US pharmacy students to consider attending graduate school, a better understanding of the financial factors involved is warranted.

A review of the literature identified one study that examined internal rate of return (IRR), a method of measuring capital investment, across pharmacy postgraduate opportunities. Hartzema and Perfetto 14 examined the IRR associated with pursuing a graduate degree and taking positions in academia or industry. In their study published in 1991, the rates of return varied from 4.4% to 8.1% for PhD positions when compared to pharmacists with a bachelor of science degree practicing in the chain community pharmacy setting. The IRR for the PharmD graduate directly employed in academia was 16% (there was no mention of residency training). Pursuing a 2-year fellowship after obtaining a PharmD degree was associated with an IRR of 10.2%. Both options resulted in IRRs significantly higher than those of PhD graduates. The authors mentioned that, from an economic standpoint, PhD graduates would have been better off had they invested in 30-year US Treasury bonds rather than graduate education. Additionally, research on the economics of pursuing graduate school has been conducted in other health professions. 28 - 31

The purpose of this study was to compare the practicing PharmD graduate to the PhD graduate from an economic perspective. Specifically, what are the monetary economic returns associated with earning a PhD degree and following the career paths that commonly result from that degree? Whereas previous research has been conducted to examine the return on investment associated with graduate education in pharmacy, revisiting the issue is warranted considering the changes that have occurred in the profession since the original research (eg, transition to a PharmD as the first professional degree). Moreover, few US pharmacy graduates are choosing to pursue graduate education, and a shortage of pharmacy faculty members exists despite efforts to recruit individuals to academia. The objectives of this study therefore were: (1) to determine the NPV and IRR for careers commonly pursued after earning the PhD degree as compared to the practicing community pharmacist; (2) to examine trends in IRR for PhD-related careers over time given available salary data.

Two methods of measuring capital investment are net present value (NPV) and IRR. Specific to this study, net present value is the current value of future wage differences between a practicing community pharmacist and a PhD graduate across careers that are commonly pursued upon graduation. The internal rate of return is the discount rate at which NPV becomes zero. In other words, IRR is the compounded return rate that can be earned from an additional capital investment (ie, an investment in graduate education). Determining the NPV and IRR for graduate school and careers associated with completion of graduate school as compared to pharmacy practice can provide insight into the difference in financial returns that can be expected from the additional investment in education.

This study was developed within the framework of human capital theory. Human capital theory posits that differences in wages can be attributed to the amount of human capital each individual has obtained. One method of investing in human capital is education. Obtaining further education, in theory, should increase human capital and therefore increase earnings through increased productivity. The economics of education, like other areas of economics, studies how scarce resources are utilized and distributed, in this case, to produce knowledge, skill, and other characteristics of education in society. Cohn and Geske described the economics of education as “(1) the process by which education is produced; (2) the distribution of education among competing groups; and (3) questions regarding how much should be spent by society (or any of its component individuals) on educational activities, and what types of educational activities should be selected.” 32

If education is an investment, ideally one would expect a positive return on that investment. But, investments are inherently probabilistic; a positive return can not be guaranteed. Return on investment also can be quite difficult to quantify. Whereas money is one form of return, nonmonetary forms of return on investment also are possible. Examples of nonmonetary returns on investment include job satisfaction, job flexibility, and autonomy. To apply this theory to the pharmacy profession, a student pharmacist will be more likely to consider pursuing graduate school if the return on investment, either monetary, nonmonetary, or both, is positive and competitive with alternative investments from which the student could choose.

The NPV and IRR were used to evaluate the financial return on investment. The NPV of an investment can be calculated by the following equation:

• Y t = annual salary resulting from earning PhD and assuming career associated with the degree
• Z t = practicing community pharmacist annual salary
• t = number of years following completion of PharmD degree from 1 to n
• r = discount rate

The IRR is calculated by determining the discount rate at which NPV is equal to zero. Therefore, the IRR can be calculated by the following equation:

• IRR = internal rate of return

The assumptions employed in Hartzema and Perfetto's study 14 for length of time to degree, age at which the student entered the PhD program, graduate student stipend, and length of postdoctoral work, could not be employed in this study given changes in pharmacy and postgraduate education. The following a priori assumptions were stated in a manner that served to maximize NPV and IRR for careers resulting from pursuance of graduate education.

• (1) The PhD program begins at the age of 24 years
• (2) Graduate school time to completion is fixed at 5 years
• (3) Graduate students are provided an annual stipend of $20,000
• (4) Graduate school involves zero out-of pocket expenses for the student (ie, cost of books, tuition, supplies, etc, is negligible)
• (5) Postdoctoral work in medicinal chemistry/molecular pharmacology (MCMP) and industrial pharmacy/pharmaceutics (IPPH) disciplines is fixed at 4 years
• (6) Individuals work until the age of 65 years
• (7) Earnings within groups (career tracks) are similar (eg, job loss, premature death, etc, similar across career tracks)
• (8) Future earnings are discounted at a rate of 3%
• (9) Tenure process is 6 years for promotion from both assistant to associate, and associate to full professor
• (10) Upon achieving rank of full professor, the academic administration process is 6 years from professor to assistant dean, assistant dean to associate dean, and associate dean to dean

Students who complete a PharmD as their first professional degree usually do so in a minimum of 6 years. However, many PharmD students earn a bachelor of science degree prior to entering the program. 33 The assumption that students begin graduate school at age 24 allowed a 6-year window in which to complete the PharmD degree. Assuming that students are able to either enter the workforce or pursue further education at age 24 was a best-case scenario assumption in that it allowed the most time for graduates to earn a salary. Graduate and postdoctoral programs vary in length. For this study, the average length of time to complete a master's degree was assumed to be 2 years; the PhD degree, 3 years; and postdoctoral work, 4 years.

The investigators used available regional data and data obtained from the National Institutes of Health (NIH) to determine an average graduate student stipend. 34 , 35 The direct out-of-pocket expenses (ie, tuition, textbooks, etc) for graduate education vary widely and could not be projected accurately; therefore, they were disregarded for purposes of this study. The commonly accepted retirement age of 65 years was employed. Additionally, a within-group similarity of earnings was assumed in the study despite inevitable variations in careers across individuals (eg, promotion, tenure, job loss, premature death). Salaries associated with academic administrative positions are significantly higher than non-administrative faculty positions. 26 The pharmacy practice track was used to evaluate and maximize the effects of administrative earnings on NPV and IRR. The largest percentage of current deans indicated pharmacy practice as their primary discipline. 26

The discount rate employed in a study should reflect the rate of return an individual could expect if investing in the next-best alternative. A discount rate of 3% was employed in this study based on conservative estimates of average prime lending rates and interest rates on US Treasury bonds. 36 , 37 A larger discount rate (eg, 5%) could have been employed; however, the 3% rate maximized the IRR and NPV for the individual who chose to pursue graduate education. The influence of fluctuations in discount rate was taken into consideration in the sensitivity analysis.

National-level data regarding the time to tenure and the manner in which PhD graduates enter and progress in academic administrative roles are not available. The investigators developed the assumptions for this variable based on input from administrative pharmacy faculty members. Those surveyed provided similar estimations regarding faculty time to receive tenure and pay increases associated with tenure and administrative positions.

Age-income profiles were constructed to assess differences in earnings across age. Although available salary data were organized according to experience rather than age, age and experience were expected to be highly correlated in the study if the other assumptions (eg, begin graduate school or enter workforce at age 24 years, fixed length of PhD program) were met. Base salary data were acquired from 2008 national salary surveys. The average PharmD salary was obtained using both the Drug Topics annual survey and the most recent Pharmacy Manpower survey. 38 , 39 The Pharmacy Manpower survey was used to determine differences in hourly rate across age. Hourly rates were converted to annual salaries based on a 40-hour work week. Percentage increases in salary were then transferred to current salary data published by Drug Topics . The Pharmacy Manpower survey indicated that relative differences in community pharmacist hourly pay across age were similar in 2000 and 2004. Data obtained from Drug Topics and the Pharmacy Manpower survey also were compared to annual data collected by one Midwest school of pharmacy. 40 A comparison of these sources indicated that data utilized from Drug Topics were conservative in nature compared to the individual school data. Given the lack of current data by age, this methodology was deemed the most reliable and valid method of determining annual salary. Academic salary data were obtained from the AACP 2008-2009 Profile of Pharmacy Faculty. 26 Industry-related pharmaceutical science salary data were obtained from the 2008 AAPS salary survey. 27 Salary information for contract research organizations (CROs) and pharmacy practice-related industry positions is not readily available. Estimations were made based on communication with PhD graduates currently employed in these areas and based on data obtained from the AAPS salary survey.

As a means of validating or refuting study findings, a longitudinal examination of IRRs was conducted to examine trends from 1982-2008. Despite changes in the structure of pharmacy curricula over the study timeframe, the original assumptions were held constant over time. Realistically, the entry-level pharmacy degree transitioned during this timeframe from the 5-year BS degree to the 6-year PharmD degree. The IRRs calculated are therefore conservative for early years, considering that the assumption of 6 years for completion of the entry-level pharmacy degree was held constant. AAPS did not conduct published salary surveys prior to 2004. Industry data therefore were not available prior to that year. Academic salary data were obtained from the annual AACP salary surveys. Graduate student and postdoctoral stipend information was calculated based on NIH predoctoral and postdoctoral award amounts during the timeframe of the analysis. 34 An assumption was made that percentage changes in hourly rates across years of experience for community pharmacists were similar throughout the study timeframe. Therefore, percentage changes in the salary of the community pharmacist were calculated based on hourly rates of pay determined in the Pharmacy Manpower survey. All years from 1982 to 2008 in which community pharmacy salary data were available were analyzed.

A sensitivity analysis was conducted to determine the variation in NPV and IRR as assumptions varied. The discount rate, length of postdoctoral work, graduate student stipend, and time to completion of graduate school each varied independently. One combination of increased graduate student stipends and decreased length of time in graduate school also was examined. Microsoft Excel (2003) was used to organize and analyze data.

Age-Income Profile

All salaries resulting from PhD career paths eventually surpassed that of the community pharmacist. The administrative career track, as expected, was associated with the largest annual salary as age increased. The net present value for all career paths is depicted in Figure ​ Figure1. 1 . The NPVs for all PhD career paths, as compared to the practicing community pharmacist, were negative. NPVs for all PhD career paths ranged from -$563,682 to -$212,271. The NPVs declined until about age 40 to 45 years, at which time the NPVs for PhD careers began to show a positive trend. Despite this positive trend in later years of employment, the cumulative NPV never caught up to the value of the practicing pharmacist by age 65 years. Cumulative NPVs for PhD careers are presented in Table ​ Table1 1 .

Net present value (NPV) for PhD-related careers as compared to career in chain community pharmacy. Abbreviations: PHPR = Pharmacy Practice; Admin = Administration; MCMP = Medicinal Chemistry/Molecular Pharmacology; IPPH = Industrial Pharmacy/Pharmaceutics; CRO = Contract Research Organization.

Cumulative Net Present Value (NPV) for PhD-Related Careers as Compared to Career in Community Pharmacy

Abbreviations: MCMP = Medicinal Chemistry/Molecular Pharmacology; IPPH = Industrial Pharmacy/Pharmaceutics; CRO = Contract Research Organization

Table ​ Table2 2 presents the IRRs for PhD careers as compared to practicing community pharmacists. The highest IRR was associated with academic administration (1.3%). Pharmacy practice (PHPR) industry/CRO careers closely followed the academic administration track with an IRR of 1.1%. Academic IPPH careers had the lowest IRR (-1.4%). Non-administrative academic IRRs ranged from -1.4% to -0.4%. Results of the sensitivity analyses manipulating the discount rate, length of postdoctoral work, and graduate student stipend are shown in Table ​ Table2. 2 . Whereas the IRR is the discount rate at which NPV is equal to zero, adjusting the discount rate only could be examined in relation to the NPV. Decreasing the discount rate to 0% increased NPVs to a range of -$310,458 for IPPH academic careers to $310,994 for the administrative track. At a discount rate of 1%, only the PHPR industry/CRO track and the administrative track show a positive NPV; additional career tracks never displayed a positive NPV regardless of the discount rate employed.

Internal Rate of Return (IRR) and Effects of Sensitivity Analyses for PhD-Related Careers Compared to Careers in Community Pharmacy

a See Text for Study Assumptions

b Annual Graduate Student Stipend = $ 40,000

c Length of Graduate Program = 3 years

d Length of Post-Doctoral Program = 2 years

e Graduate Student Stipend = $ 30,000; length of graduate school = 4 years

Sensitivity analysis of the length of postdoctoral work for MCMP and IPPH PhD careers led to positive changes in NPV and IRR. Basing calculations on a 2-year postdoctoral experience, IRRs ranged from 0.2% to 0.7%, with NPVs ranging from -$334,859 to -$303,383. Determining the effects of increases in graduate student stipends on IRR indicated that increasing the assumed stipend to $30,000 increased IRRs from a range of -0.7% for MCMP and IPPH industry careers to 2.4% for administrative careers. Increasing the annual graduate student stipend to $40,000 increased IRRs from a range of -0.5% for MCMP and IPPH industry careers to 2.8% for academic administration careers.

Time to complete graduate school also was examined as it impacted the IRR. IRRs ranged from 0.4% to 4.0% when the time to complete graduate school was decreased to 3 years. The lowest IRRs were associated with MCMP and IPPH industry careers and IPPH academic careers, whereas the highest IRRs were associated with academic administrative and PHPR industry/CRO careers. IRRs associated with decreasing graduate school time to completion to 4 years ranged from -0.3% to 3.0%. One additional sensitivity analysis was conducted to examine the effect on IRR when considering a combination of decreased time to degree (4 years) and increased graduate student stipend ($30,000). IRRs ranged from -0.1% for MCMP and IPPH industry careers to 3.3% for academic administration careers. Every calculated net present value resulting from the sensitivity analysis was negative.

Longitudinal IRR Analysis

Figure ​ Figure2 2 indicates the extent to which IRRs have decreased over the study period. In 1982, the IRRs for PHPR academic and PHPR administrative tracks were 7.3% and 7.2%, respectively, compared to IRRs of -1.3% and 1.3% in 2008. The MCMP track IRR ranged from 4.1% in 1982 to -1.0% in 2007. Similarly, the IPPH track IRR ranged from 4.4% in 1987 to -1.5% in 2007. MCMP and IPPH academic career tracks were consistently lower than PHPR and administrative tracks given postdoctoral expectations. Analysis of the IRRs associated with industrial career tracks from 2004 to 2008 also showed a negative trend. Over the study timeframe, the IRR for the PHPR industry/CRO track dropped from 4.2% in 2005 to 1.1% in 2008. Given an inability to differentiate between MCMP and IPPH industrial track salaries based on AAPS data, the MCMP and IPPH industrial tracks were calculated based on the same data from AAPS. IRRs for the study period dropped from 1.3% in 2004 to -1.2% in 2008 for both career tracks.

Internal rate of return (IRR) for PhD careers as compared to practicing community pharmacist: 1982-2008 (data for industry career tracks only available from 2004-2008). Abbreviations: PHPR = Pharmacy Practice; Admin = Administration; MCMP = Medicinal Chemistry/Molecular Pharmacology; IPPH = Industrial Pharmacy/Pharmaceutics; CRO = Contract Research Organization.

IRRs allow investors (eg, prospective graduate students, prospective faculty members) to compare the probable financial outcomes associated with various career options. The results of this study, while perhaps not surprising, quantify the opportunity cost associated with pursuing a graduate degree after earning a PharmD degree. US pharmacy school graduates who choose to pursue graduate school can expect a much lower return on their investment than if they had invested in a US Treasury bond or the stock market. Thus, from an economic standpoint, there is no reason to expect graduates of PharmD programs to consider pursuing the PhD degree.

As expected, the largest IRR in the academic setting was associated with the administrative career path. However, the majority of individuals who obtain PhDs and enter the workforce never hold administrative positions. Only 9.7% of pharmacy faculty members held administrative positions in 2008. 26 Thus, the IRRs and negative NPVs associated with non-administrative postgraduate education tracks, including pharmacy practice, industrial pharmacy, and medicinal chemistry, are a better representation of the PhD pharmacy faculty population.

Early differences in income between practicing pharmacists and pharmacy graduates who pursue graduate school had the greatest impact on IRRs. Essentially, the graduate student accumulates debt of approximately $400,000 to $600,000 (depending on postdoctoral requirements) realized as foregone income he/she could have earned in pharmacy practice while pursuing graduate school. Given the nature of returns on investments, interventions that produce the greatest impact, dollar for dollar, are those that occur early in the process, like tuition support, increased stipends, decreased time to earn the degree, early career increases in salary, or a combination of the aforementioned options, as these compound throughout the career of the PharmD/PhD graduate. Substantial increases in pay later in a career do not have as great of an impact as early interventions when taking into consideration the discount rate on earnings.

Increasing graduate school stipends to the $40,000 level (a level similar to residency and fellowship stipends) in the sensitivity analysis increased the IRRs substantially. However, given that the original IRRs were quite low, even a 100% to 400% increase did not raise IRRs to a level where pursuit of graduate school and the resulting careers were financially attractive choices. This stipend of $40,000 also might be considered representative of the pharmacist-graduate student who works part-time as a practicing pharmacist to supplement his/her graduate school stipend. Given hourly earnings for part-time pharmacists, it is quite feasible for a graduate student to double his/her income. However, working part-time also can increase the amount of time necessary to complete graduate school, potentially negating any increase in the IRR attributed to part-time practice.

Decreasing the time necessary to complete graduate school increased the projected IRRs of PhD career tracks by a larger magnitude than increasing graduate student stipends. However, the maximum IRR resulting from a decrease of graduate program length to 3 years was still only 4%. In previous research, decreasing the time necessary to complete graduate school and increasing stipends to levels comparable to those of residents and fellows were the 2 factors that pharmacy students indicated would most positively influence their decision to pursue graduate school. 22 From an educational standpoint, however, the feasibility of completing requirements for the PhD in a 3-year timeframe is questionable. Decreasing PhD completion time to 4 years and increasing stipends to $30,000 did increase IRRs. However, the rates of return were still relatively lower than those of the economic market, especially for MCMP and IPPH careers.

Economic theory posits that society should distribute resources to areas that provide a rate of return greater than or equal to the market rate of return. If other means of entering academia (eg, residencies or fellowships) or other careers often associated with having a PhD degree exist that provide a higher rate of return, resources should be allocated to those areas. The decreased length of time necessary to complete these post-PharmD options should make the career paths more attractive from an economic perspective. However, assuming an average annual resident salary of $40,000, the pharmacist who completes a 2-year residency and is then employed in pharmacy academia can expect an IRR of only 2%, which is higher than the IRR for pharmacists who choose to pursue graduate school but still low considering other training and employment alternatives. Fellowships can vary in length and requirements regarding residency training. If the fellow had completed a PGY1 residency and then completed a 2-year fellowship, the rate of return would be 1%. While not exceptional rates of return, the decrease in the length of the programs places these post-PharmD options at an economic advantage compared to graduate education as a means of entering an academic career. The clinical focus of the profession also serves as a good recruitment tool for residency and fellowship programs.

Comparing results of the study by Hartzema and Perfetto to the current study reveal significant decreases in IRR in the current study regarding PhD career paths. 14 Hartzema and Perfetto obtained IRRs ranging from 10.2% for pharmacy graduates completing 2-year fellowships to 4.4% for PhD graduates completing a 2-year post-doctoral fellowship. PharmD graduates who entered academia directly had an IRR of 16% when compared to BS graduates employed in the community setting. In 1982, the starting community pharmacist salary was approximately $27,000, compared to an average assistant professor salary across common pharmacy departments of approximately $29,100. Academia at one time provided financial incentive in terms of higher starting salaries as compared to pharmacy practitioners. That incentive no longer exists. Academic salaries do increase at a rate greater than that of the community practitioner; however, economic analysis indicates that the IRRs for academic careers are still low, even after completing only a 1-year residency.

Perhaps the most striking finding in this study pertained to the longitudinal analysis, which indicated that, from 1982-2008, the IRRs associated with PhD academic careers decreased substantially. Disregarding changes from BS to PharmD length of degree requirements makes this analysis conservative in nature. Even if the accuracy of study assumptions and available salary data are questioned, observation of IRRs over time, holding assumptions constant, indicates that IRRs have indeed decreased for academic careers. Public institutions' reliance on government funding could potentially limit the ability of said institutions to provide salaries that compete with salaries provided by private for-profit corporations such as community pharmacies. However, failure to provide starting faculty salaries commensurate with those of community practitioners economically devalues graduate education from the perspective of the student pharmacist. Despite an investment in postgraduate pharmacy education, the PharmD/PhD graduate initially will be paid approximately $20,000 less annually than could be earned in the community setting. The economic incentive for earning a PhD degree therefore is lacking.

Indeed, there is another lens through which the current faculty shortage and financial differences between practicing pharmacists and those who seek employment in careers resulting from PhD education can be viewed. The economic perspective does not take into consideration all factors that could motivate a student pharmacist to pursue graduate education. Arguably, academic positions do offer substantial non-monetary rewards, but the financial component of said positions has worsened even if it is assumed that non-fiscal rewards are held constant over time. Individuals may feel called to pharmacy education regardless of financial ramifications of the decision. While the calling to be an educator is desirable and may attract some individuals to academic careers, self-recruitment may not be sufficient to ensure an adequate number of pharmacy educators in the future.

The community pharmacy “bubble” may burst with respect to increases in community pharmacist salaries; however, there remains a moderate excess demand over available supply for pharmacists, specifically in community and institutional settings. 41 With an increase in the number of pharmacy schools/colleges, the supply of pharmacists is likely to increase. Furthermore, the shortage of pharmacy faculty members is likely to increase. The potential exists for a supply/demand equilibrium or pharmacist surplus that could positively influence recruitment of PharmD graduates to graduate education. However, reliance on this recruitment technique, ie, pursuing graduate education out of necessity or desperation, does little to increase the perceived value of graduate education to student pharmacists.

Faculty encouragement of pharmacy students to pursue graduate education is associated with increased student interest in pursuing graduate school. 22 Relying on faculty members to encourage students to pursue graduate school operates under the assumption that faculty members enjoy their occupations and promote positive aspects of their career choices to students. Moreover, as a smaller percentage of pharmacy-educated individuals (both US- and foreign-educated) comprise the total number of pharmacy educators, the profession eventually may rely on a non-pharmacy educated majority of its faculty members to provide encouragement to student pharmacists to consider careers resulting from completion of pharmacy graduate school.

If academic pharmacy desires to recruit US pharmacy graduates to graduate education, justification as to why pharmacy graduates should forego practitioner income and be willing to assume a starting salary approximately $20,000 less than that of a pharmacy practitioner should be apparent. If the discrepancy in IRR and starting salary upon completion of the graduate degree is not justifiable, efforts should be taken to increase the perceived value of the pharmacy graduate degree.

Limitations

Conducting this study on the projection of future earnings was limited by the fact that it is a projection. Nevertheless, employing assumptions based on current data is the most appropriate manner in which valid projections regarding the future can be made. Sensitivity and longitudinal analyses supported the findings in this study. One career characteristic not examined in this study was the difference in hours worked across professions. The authors assumed hours to be similar across community pharmacy, academic, and industry career tracks. One aspect of careers resulting from completion of graduate education that was not taken into consideration was the extent to which faculty members who are registered pharmacists supplement their income by working outside of academia as pharmacy practitioners. Additionally, the extent to which pharmacy faculty members supplement their income through consulting services was not taken into consideration. An additional limitation is the availability and accuracy of salary data for all career tracks. Whereas a portion of the data sources are quite reliable, some data sources are questionable. However, the data employed in the study were the best currently available data sources. Multiple sources of community pharmacy salary data were analyzed in an effort to increase the reliability and validity of available data.

Completion of a PhD degree and employment in an academic or industrial setting was associated with low positive or negative internal rates of return. Moreover, net present value for all PhD-related career paths was negative as compared to the practicing community pharmacist. Longitudinal analysis showed a decreasing trend in IRRs associated with academic- and industry-related PhD careers. Considering the shortage of pharmacy faculty members, the likelihood of increased vacancies within academic pharmacy as the current faculty ages and more schools/colleges open, and the small percentage of graduates of US colleges and schools of pharmacy that comprise pharmacy PhD programs, recruitment methods should be implemented that take into consideration both non-economic and economic characteristics of the career paths that can result from completion of the PhD degree. From an economic perspective, pharmacy educators must be able to demonstrate the benefits associated with obtaining a PhD degree and pursuing PhD-related careers. Moreover, differences in starting salary for practicing pharmacists and those who enter academia should be justifiable to prospective academicians.

Build a Career You'll Love

Phd chemist salary in the united states.

How much does a Phd Chemist make in the United States? The salary range for a Phd Chemist job is from $51,582 to $93,950 per year in the United States. Click on the filter to check out Phd Chemist job salaries by hourly, weekly, biweekly, semimonthly, monthly, and yearly.

• Per semimonth
• Connecticut
• District of Columbia
• Massachusetts
• Mississippi
• North Carolina
• North Dakota
• New Hampshire
• Pennsylvania
• Rhode Island
• South Carolina
• South Dakota
• West Virginia
• San Francisco, CA
• Washington, DC
• Chicago, IL
• New York, NY

HOW SHOULD YOU USE THIS DATA?

Employees: Use this as a guide for salary expectations, but be aware that responsibilities can change across companies for the same job title, so there may be differences between this data, other free site and our subscription products bought by employers.

Employers: This data could be used as reference point in your market pricing, but not the only source, due to differences across jobs locations, and sizes of companies.Consider additional sources like our Employer reported data.

Our consulting team crafts efficient, data-driven solutions using the power of CompAnalyst ® , ensuring your challenges are met head-on.

The trusted data and intuitive software your organization needs to get pay right.

Let our management tool - JobArchitect™ streamline your job description process. Say goodbye to the hassle of crafting job descriptions.

Highest Paying Cities for Phd Chemist in the United States

States with higher salaries for phd chemist, how much do similar professions get paid in the united states, how much should you be earning, what does a phd chemist do.

You can use your PhD in chemistry to become a materials scientist, a chemical engineer, or even a medicinal chemist.

View Job Skills and Competency Data for more than 15,000 Job Titles, 18 Industries, and 26 Job Families.

Most Common Benefits for Phd Chemist

Related companies for phd chemist in the united states, frequently asked questions, do i receive fair pay as a phd chemist currently, what are the responsibilities of a phd chemist, how much do similar jobs to phd chemist make.

• Psychologist Phd
• Phd Engineer
• Phd Scientist
• Phd Biology
• Phd Engineering
• Phd In Finance
• Phd Neuroscience
• Phd Physics

Where can I get a higher Phd Chemist salary in the United States?

What is the phd chemist's salary range in the united states, career insights.

Our pharmacy programs provide a strong foundation in pharmaceutical basics while cultivating scholars in both fundamental and applied research methods.

• Request Information

Why Pharmacy at UMB

Top-tier training.

Engaging student pharmacists in problem-solving, critical thinking, and continuous self-assessment, our pharmacy programs prepares you for a career where you'll play pivotal roles in interprofessional teams. With collaborative group work and access to nationally and internationally renowned faculty along with cutting-edge technology, our curriculum offers an environment primed for career advancement in the field of pharmacy.

Research Opportunities

Our research endeavors embrace interdisciplinary collaboration, offering students access to cutting-edge facilities encompassing nanobiotechnology, mass spectrometry, computer-aided drug design, and translational medicine centers. Among our diverse research focuses are  comparative effectiveness and patient-centered outcomes research, pharmaceutical policy, cannabis therapeutics, pharmacoeconomics, pharmacoepidemiology, drug formulation, drug transport and delivery, industrial pharmaceutical research, and translational and regulatory sciences.

My research is focused on gaining insights into the structure and dynamics of the dengue virus nonstructural 5 (NS5) protein. Specifically, my research aims to characterize the structural dynamics of dengue NS5 in its apo form, and in complex with its different RNA partners, to gain mechanistic insights into its catalytic functions.

MEET YOUR FACULTY

Enhance your educational journey with our distinguished faculty, consisting of accomplished scholars and experienced pharmaceutical professionals. Tap into their extensive knowledge and practical wisdom as they lead you through our comprehensive programs, resulting in transformative learning experience that equips you for success in the ever-evolving realm of pharmacy.

Programs by Degree Type

Select a degree/certificate to see your program options

• Certificate

620 W. Lexington St. Baltimore, MD 21201 (410) 706-3100

University of Maryland Graduate School. All Rights Reserved.

• Privacy Policy
• Web Accessibility

• Future Students
• Parents and Families

Rhody Today

Uri college of pharmacy ranked among nation’s ‘best pharmacy schools’.

Doctor of Pharmacy program ranks 31 nationally, College’s highest mark, in U.S. News & World Report rankings

KINGSTON, R.I. — April 9, 2024 — The University of Rhode Island College of Pharmacy’s programs are again ranked among the top pharmacy colleges in the country, with the Doctor of Pharmacy program making an impressive rise over the four years since the last survey, according to the latest U.S. News & World Report rankings.

The College’s PharmD program is now ranked number 31 among the 141 pharmacy colleges in the United States, the college’s highest rank to date. The program has been rising steadily through the ranks in recent years, improving from number 40 in the last survey in 2020, and number 46 in 2016.

“We are thrilled to share that the URI College of Pharmacy has ascended to the 31st spot in U.S. News & World Report’s Best Colleges of Pharmacy rankings, a climb from 40th,” said Dean Kerry LaPlante . “This achievement is due to the unwavering dedication of our alumni, faculty, staff, and students. This ranking reflects our commitment to educational excellence, impactful research, and service to community health.”

The U.S. News & World Report’s rankings were computed from the results of peer assessment surveys completed by deans, other administrators or faculty members at accredited degree schools. Respondents rated the academic quality of programs on a scale of 1 (marginal) to 5 (outstanding).

The URI College of Pharmacy continues to be a national leader in pharmacy education and research, garnering the most research funding among all colleges of pharmacy in New England over the last year, according to the American Academy of Colleges of Pharmacy. This year, the College has the highest first-year postgraduate residency placement rate in New England at 85 percent, placing it in the top 10 in the country, and a second-year placement rate of 100 percent; a first-time pass rate of 86 percent on the North American Pharmacist Licensure Examination, and a graduate employment rate of 99 percent.

“In this proud moment, we also extend our appreciation to our alumni, whose support has been crucial in raising our profile both nationally and globally,” LaPlante said. “As we celebrate, we remain committed to advancing our standards and embracing the ongoing work that deserves such recognition.”

In addition to the 0-6 PharmD program, allowing students to complete the degree just six years after graduating high school, the URI College of Pharmacy also offers Master’s and Ph.D. programs , as well as a Bachelor of Science in Pharmaceutical Sciences . Visit the URI College of Pharmacy website for more information and to apply.

Salaries for Pharmacist with a JD, MD, PhD or Equivalent

According to our 100% employer reported salary sources the median salary for a Pharmacist with a JD, MD, PhD or Equivalent is $149,333 - $154,465 . Please try our salary wizard to explore how other factors like location, Years of experience and number of direct reports can impact your base pay and bonus.

UNC-Chapel Hill graduate programs ranked among best in nation

U.S. News & World Report’s 2024 “Best Graduate Schools” list named multiple Carolina graduate degree programs in the top 10, including UNC Eshelman School of Pharmacy at No. 1.

Numerous UNC-Chapel Hill graduate programs received high rankings – 20 were among the top 10 in the nation in their respective categories – as part of U.S. News & World Report’s “Best Graduate Schools” list.

For the third time in a row (2016, 2020 and 2024), UNC Eshelman School of Pharmacy is the top pharmacy school in the U.S. The rankings are based on a survey of peers from accredited pharmacy schools across the country and are published every four years.

The Gillings School of Global Public Health was ranked second out of 213 schools and programs of public health in the U.S. for the seventh consecutive rankings period. The Gillings School has also maintained its position as the top public school of public health and has been ranked among the top schools and programs of public health by U.S. News since the magazine first ranked public health schools in 1987. U.S. News & World Report does not rank all graduate programs each year.

“Carolina’s graduate programs are exceptional, and it’s no surprise that our schools are ranked so highly among peer institutions by U.S. News and World Report, as well as other measures,” said UNC-Chapel Hill Interim Chancellor Lee H. Roberts. “Carolina is always proud to be recognized for our dedication to a world-class education. Every one of our graduate programs contributes to making us the leading public research university.”

Altogether, 23 programs increased their rankings, including multiple programs in the Gillings School of Global Public Health, School of Nursing, School of Education, Kenan-Flagler Business School and UNC School of Law.

“These rankings represent the hard work of our faculty, staff and students who are dedicated to moving Carolina forward through their incredible efforts each day,” said UNC-Chapel Hill Provost Chris Clemens. “It is gratifying to see this public recognition of their commitment to the mission of our graduate programs in research, teaching and public service. Even more than in the rankings, the proof of their work is the quality of our students and our passionate alumni who lead in so many fields.”

The School of Social Work moved up three spots in the latest rankings to a tie for fourth overall and is tied for second among public universities.

This year marks the first time since U.S. News & World Report began ranking law schools in 1987 that UNC School of Law has reached No. 20 out of 196 law schools. The UNC School of Law is also the seventh-ranked public law school.

Additional UNC-Chapel Hill rankings for 2024 follow.

Please note: Not all graduate programs are ranked by U.S. News & World Report every year. For a complete list of rankings for UNC-Chapel Hill, visit the U.S. News & World Report website .

UNC Eshelman School of Pharmacy

Gillings school of global public health.

• First public, second overall

Specialty Areas

• Health Behavior, second
• Biostatistics, third
• Epidemiology, third
• Health Policy and Management, fourth
• Environmental Health Science, eighth

School of Social Work

• Tied for fourth

School of Nursing

• Nursing Schools, Master’s Programs, tied for eighth
• Nursing Schools – DNP Programs, tied for 17th
• Nursing Master’s, Administration/Management, fourth
• Nursing Master’s, Nurse Practitioner: Psychiatric/Mental Health, fourth
• Nursing Master’s, Nurse Practitioner: Family, tied for sixth
• Nursing DNP, Psychiatric/Mental Health, third
• Nursing DNP, Family, tied for sixth

UNC Kenan-Flagler Business School

• Tied for 20th
• Real Estate, ninth
• Accounting, tied for 13th
• Executive MBA, 14th
• Management, 16th
• Production Operations, 16th
• Finance, 20th
• Marketing, tied for 25th

UNC School of Education

• Tied for 25th
• Special Education, tied for 13th
• Elementary Teacher Education, tied for 14th
• Educational Psychology, tied for 15th
• Education Policy, tied for 16th
• Secondary Teacher Education, tied for 17th
• Educational Administration, tied for 17th
• Curriculum and Instruction, tied for 22nd

College of Arts and Sciences

Computer science.

• Overall, 27th

Public Affairs

• Overall, 39th (Master of Public Policy)

As part of the public affairs category, U.S. News and World Report ranked Carolina programs and specialty areas based in the School of Government and the College of Arts and Sciences’ department of public policy.

School of Government

• Public Affairs, 23rd (Master of Public Administration)
• Local Government Management, second
• Leadership, 10th
• Public Finance, 18th

UNC School of Law

• Legal Writing, tied for 20th
• Criminal Law, tied for 20th
• Tax Law, tied for 20th
• Business/Corporate Law, tied for 22nd
• Clinical Training, tied for 23rd
• Contracts/Commercial Law, 23rd
• Health Care Law, tied for 28th
• Constitutional Law, tied for 29th
• Environmental Law, tied for 45th
• International Law, tied for 52nd
• Intellectual Property Law, tied for 53rd
• Trial Advocacy, tied for 118th

UNC School of Medicine (additional Rankings will be available at a later date)

• Audiology, tied for third
• Occupational Therapy, fifth
• Physical Therapy, 11th
• Speech Language Pathology, 12th

School of Education students networked in Raleigh with representatives from 11 state agencies.

Global studies scholar aspires to diplomacy

After earning a master’s degree, Kat Goodpaster became assistant director of Carolina’s Russian Flagship Program.

Public Service Awards go to 7 people, 2 groups

The Carolina Center for Public Service honored work on health disparities, refugee aid and more.

Broadway writer brings new comedy to PlayMakers

Fresh off the debut of her musical adaptation of “The Notebook,” Bekah Brunstetter ’04 will debut “The Game” in Chapel Hill.

Arts Everywhere Day set for April 12

The eighth annual campus-wide event celebrates artists creating in all mediums.

Are you ready to run, hide and fight/defend?

Active Shooter and Critical Incident Response training customizes emergency preparedness to your workspace.

Brandwein’s Bagels offers authentic NYC flavor

MBA graduate Alex Brandwein turned his love of New York-style bagels into a local business.

Bernice Meja has a passion for fixing broken systems

The discovery led her to a master’s program at the School of Information and Library Science.

Share on Mastodon

University of South Florida

Main Navigation

Nearly two dozen graduate programs at USF considered among the best in America

• April 9, 2024

University News

By Althea Johnson , University Communications and Marketing

The University of South Florida is home to nearly two dozen graduate programs considered among the best in America, according to new rankings released today by U.S. News & World Report. USF features 23 graduate programs ranked inside the top 100 among all public and private institutions, including 11 ranked in the top 50.

USF’s highest-ranked programs are industrial and organizational psychology at No. 3, criminology at No. 18 and audiology, which comes in at No. 22. 

Among USF Health’s ranked programs, nursing anesthesia jumped 58 spots into the top 50, the physical therapy program rose by double digits to No. 33 and the nursing master’s program now sits in the top 25 at No. 24. 

In addition, USF’s social work and part-time MBA programs both saw double-digit gains and the education program broke into the top 50.  

“We are thrilled that many University of South Florida graduate programs are included among the nation’s best in U.S. News & World Report’s rankings,” USF President Rhea Law said. “This recognition underscores the commitment of our faculty and staff, who continue to provide high-quality programs that empower our students to enhance their skills, expand their knowledge and progress in their careers by earning an advanced degree.”

Full list of USF’s top 50 programs:

Industrial and Organizational Psychology* – 3 Criminology* – 18 Audiology – 22 Nursing – Master’s – 24 Library and Information Studies* – 27 Public Health – 29 Physical Therapy – 33 Nursing – Doctor of Nursing Practice – 34 Nursing – Anesthesia – 36 Rehabilitation Counseling* – 46 Education – Overall – 48

Full list of USF’s 51-100 programs:

Healthcare Management*– 52 Speech-Language Pathology – 52 Business ‐ Part‐time MBA – 53 Earth Sciences* – 54 Pharmacy – 60 Physician's Assistant/Associate Studies* – 65 Fine Arts* – 73 Social Work – 83  Statistics* – 86  Business – Full-time MBA – 87  Sociology* – 92 Psychology* – 97  

As U.S. News does not release new rankings for every program, every year, rankings denoted with an asterisk have been republished this year. U.S News also announced that medical, engineering and clinical psychology school rankings will be released at a later date. 

According to U.S. News, rankings are generated through “ranking indicators” derived from reputation and/or data reported by each institution.  For some programs, U.S. News evaluates key areas such as expert opinions in the field, opportunities for student engagement, resources for student support and career success, as well as faculty and student performance, in terms of existing credentials, research impact and metrics such as student job placement.

In addition to the graduate program rankings, in September 2023 U.S. News ranked USF as one of the nation’s top 50 public universities for the fifth consecutive year , and the university earned its highest ranking ever among all universities public or private. 

Return to article listing

U.S. News and World Report

News Archive

Learn more about USF's journey to Preeminence by viewing Newsroom articles from past years.

USF in the News

Business observer: usf embraces opportunities to connect with more businesses.

April 10, 2024

NPR: A professor worried no one would read an algae study. So she had it put to music

April 4, 2024

Tampa Bay Times: Tampa doctors fit device that restores arm movement to stroke victims

March 27, 2024

Associated Press: Debate emerges over whether modern protections could have saved Baltimore bridge

More USF in the News

• canva icon Canvas
• Panther Mail (students)
• Arts & Film
• Business & Economy
• Campus & Students
• College Knowledge
• Health & Behavior
• Humanities & Society
• Science & Engineering
• University News
• Chapman Magazine
• Chapman Forward
• Maps & Directions
• Visit Chapman
• Discover Chapman
• Facts & Rankings
• Campus Services
• Degrees & Programs
• Schools & Colleges
• Academic Calendar
• Faculty Directory
• Course Catalogs
• International Study
• Undergraduate Admission
• Undergraduate Application
• Graduate Admission
• Graduate Application
• Affordability
• Financial Aid Calculator
• Campus Tours
• Get Involved
• Career Support
• Diversity & Inclusion
• Fish Interfaith Center
• Health & Safety
• Residence Life
• Student Life
• Pre-Award Administration
• Post-Award Administration
• Research Integrity
• Institutes & Centers
• Center for Undergraduate Excellence
• Graduate Research Support
• Contact Development
• Areas to Support
• Alumni Involvement
• Prospective Students
• Current Students
• Faculty & Staff
• Parents & Families
• All Directories

School of Pharmacy Jumps Almost 20 Spots in Rankings

Chapman University’s School of Pharmacy (CUSP) rose almost 20 spots in U.S. News & World Report’s 2024 rankings of Best Pharmacy Schools.

Chapman University’s School of Pharmacy (CUSP) rose almost 20 spots in U.S. News & World Report’s 2024 rankings of Best Pharmacy Schools .

CUSP jumped from No. 99 last year to No. 80 this year, and is the No. 8 pharmacy school in California.

Schools offering a Doctor of Pharmacy degree are peer-ranked by academic quality and other factors like location, financial aid and job placement, according to U.S. News .

“ CUSP faculty, staff and students are pleased to see our school’s continued march up in the rankings,” Dean Rennolds Ostrom said. “This is one step toward achieving our higher goals, and we are eager to continue the hard work that will continue to increase our reputation and rank in all aspects of our school.”

CUSP , which is based at Chapman’s Rinker Campus in the health care hub of Irvine, was third in the state in phase 1 residency match results and recently partnered with City of Hope Orange County for Pharm.D. graduates. CUSP faculty received more than $3 million in research funding last year for subjects including asthma, HIV and antibiotics. 

Almost 90% of CUSP alumni passed the national board exam on their first try. Students were active in national competitions and organizations, including Elyn Lam (PharmD ’24), who was given the Student Leadership Award by the American Society of Health-System Pharmacists.

Media Contacts

Newsroom site, chapman site, services & policies.

© 2023 Chapman University

• Arts & Film
• Business & Economy
• Campus & Students
• Health & Behavior
• Humanities & Society
• Science & Engineering

Your Header Sidebar area is currently empty. Hurry up and add some widgets .

• UB Directory
• Office of the Provost >
• Communications from the Provost >
• UB schools among the best in U.S. News & World Report’s Best Graduate Schools rankings

UB schools among the best in U.S. News & World Report’s Best Graduate Schools rankings

Photo: Douglas Levere

By David J. Hill

Release Date: April 9, 2024

BUFFALO, N.Y. – Several schools within the University at Buffalo, New York’s flagship, are ranked among the top nationwide in U.S. News & World Report’s Best Graduate Schools rankings , released this morning.

The School of Pharmacy and Pharmaceutical Sciences is among the top 20 in the country, coming in at No. 19 overall and 18th among public universities.

“This achievement is a testament to our relentless pursuit of groundbreaking research, transformative discoveries, and unwavering commitment to the success of our students,” said Gary Pollack, PhD, dean of the School of Pharmacy and Pharmaceutical Sciences. “Our top 20 ranking reaffirms our steadfast commitment to cultivating the next generation of pharmacy and pharmaceutical science leaders who will push the boundaries of scientific inquiry, drive innovation in patient care, and elevate the standards of pharmaceutical research on a global scale.”

The School of Social Work is once again in the top 25, coming in at 24th nationally and No. 13 among public universities.

The School of Nursing’s Doctor of Nursing Practice (DNP) program moved up 11 spots to 34th in the country and No. 24 among public universities. In addition, the nursing anesthesia program was ranked 22nd.

“We are immensely proud to rank among the best DNP programs in the United States,” says School of Nursing Dean Annette Wysocki, PhD. “Our commitment to exceptional nursing education cultivates discipline of the mind to educate highly discerning nurse practitioners, who are indispensable in addressing the nation’s critical shortage of primary care providers. Quality nursing education remains paramount in safeguarding the health and wellness of our community.”

UB’s Graduate School of Education moved up four spots to No. 54 in Best Education Schools. Among public universities, the Graduate School of Education ranks 42nd. “Our steady climb in the rankings over the years is a testament to the hard work and high-quality research of GSE faculty,” says dean Suzanne Rosenblith, PhD.

The School of Public Health and Health Professions moved up four spots, to No. 46 nationally and No. 29 among public universities. Its programs in occupational therapy (41) and physical therapy (74) were also ranked, as was biostatistics (22).

Meanwhile, the School of Law moved up 17 places to No. 108 among Best Law Schools nationwide and 56th among public universities.

The School of Management’s MBA program came in at No. 74 in Best Business Schools and 38th among public universities, making it the highest rated business school within SUNY.

In addition, UB’s graduate programs in audiology (22) and speech language pathology (32) were also ranked this year.

Media Contact Information

David J. Hill Director of Media Relations Public Health, Architecture, Urban and Regional Planning, Sustainability Tel: 716-645-4651 [email protected]

Do you have questions or comments for the Office of the Provost? Let us know your thoughts and we’ll be happy to get back to you.

PhD Excellence Initiative

A campus-wide, student-centric effort to ensure that UB’s PhD programs remain among the strongest in the world.

Recent University News

• 4/11/24 Friday, April 12 JSMBS Bike Tune Up Event Postponed
• 4/11/24 Educating providers about female genital cutting
• 4/11/24 Time to rethink school discipline
• 4/11/24 New study probes macrophages’ role in developing pulmonary fibrosis
• 4/11/24 SUNY funding to boost mental health services at UB

Graduate Program Manager

• Madison, Wisconsin
• SCHOOL OF MEDICINE AND PUBLIC HEALTH/ANATOMIC PATHOLOGY
• Academic Services and Student Experience
• Partially Remote
• Staff-Full Time
• Opening at: Apr 11 2024 at 16:35 CDT
• Closing at: May 3 2024 at 23:55 CDT

Job Summary:

The Graduate Program Manager will serve as the main department contact for all graduate and undergraduate educational endeavors. The successful candidate will report to the Chief Administrative Officer. The primary responsibilities for this position are developing, implementing and managing student and academic services for the Department of Pathology and Laboratory Medicine including the Cellular and Molecular Pathology (CMP) Graduate Program (on average enrolls 8-12 new graduate students per year) with overall enrollment of approximately 55 students. This position is responsible for the day-to-day operations of the graduate program including recruitment, training and matriculation of students and course support. Other responsibilities include academic oversight and coordination of graduate and undergraduate courses, program related grant renewals (ie T32), assistance with medical student clerkships and other rotators, as needed, and participation on educational committees.

Responsibilities:

• 20% Serves as the expert resource for applicants, current students, faculty, staff, and other stakeholders of an academic program
• 15% Manages the response, support, and advocacy for graduate students while continuously improving the student experience and overall graduate program
• 20% Oversees programming, services, and events to promote professional development and academic success
• 20% Provides comprehensive advising services promoting graduate student success, retention, and degree completion. Advises on programs, graduate education, and university policies, processes, and procedures. Monitors degree progress and assists students in navigating resources and systems throughout the student lifecycle from matriculation to degree completion
• 5% Manages graduate student funding including, but not limited to, fellowships, scholarships, training grants, or assistantships from department, university, and/or outside sponsors. May prepare and/or submit funding proposals
• 10% Maintains compliance with graduate program(s), school/college, and university requirements and technology systems related to admissions, assessment, academic degree progress/requirements, and program review. Makes policy and procedure recommendations and/or changes
• 5% Oversees staff and/or graduate program functions
• 5% Manages the program T32 participating in the annual progress report process as well as grant renewal submissions

Institutional Statement on Diversity:

Diversity is a source of strength, creativity, and innovation for UW-Madison. We value the contributions of each person and respect the profound ways their identity, culture, background, experience, status, abilities, and opinion enrich the university community. We commit ourselves to the pursuit of excellence in teaching, research, outreach, and diversity as inextricably linked goals. The University of Wisconsin-Madison fulfills its public mission by creating a welcoming and inclusive community for people from every background - people who as students, faculty, and staff serve Wisconsin and the world. For more information on diversity and inclusion on campus, please visit: Diversity and Inclusion

Preferred Master's Degree

Qualifications:

Knowledge/Skills Required: -Excellent organizational skills and ability to exercise initiative when necessary -Strong computer skills particularly with databases, e-learning, word-processing, PowerPoint and computerized student records -Personal or professional experiences relevant to effectively and inclusively engaging and building relationships with learners, faculty, and staff -Maintains confidentiality -Ability to take initiative, coordinate with others, and seek solutions to problems Knowledge/Skills Preferred: -At least one year of experience working with college and/or graduate students providing academic advising, academic support and timetable services -Experience with the Graduate School and other sources of campus support -Knowledge of University policies and procedures desirable

Full Time: 100% This position may require some work to be performed in-person, onsite, at a designated campus work location. Some work may be performed remotely, at an offsite, non-campus work location.

Appointment Type, Duration:

Ongoing/Renewable

Minimum $53,700 ANNUAL (12 months) Depending on Qualifications Employees in this position can expect to receive benefits such as generous vacation, holidays, and sick leave; competitive insurances and savings accounts; retirement benefits. Benefits information can be found at ( https://hr.wisc.edu/benefits/ ). SMPH Academic Staff Benefits flyer: ( https://uwmadison.box.com/s/r50myohfvfd15bqltljn0g4laubuz7t0 ).

Additional Information:

The selected applicant will be responsible for ensuring their continuous eligibility for employment in the United States on or before the effective date of the appointment. University sponsorship is not available for this position. UW-Madison is not an E-Verify employer, and therefore, is not eligible to employ F1-OPT STEM Extension participants.

How to Apply:

To apply for this position, please click on the "Apply Now" button. You will be asked to upload a current resume/CV and a cover letter briefly describing your qualifications and experience, and a document listing contact information for three (3) references, including your current/most recent supervisor. References will not be contacted without prior notice.

Tia Seguin [email protected] 608-263-3731 Relay Access (WTRS): 7-1-1. See RELAY_SERVICE for further information.

Official Title:

Graduate Program Manager(AE093)

Department(s):

A53-MEDICAL SCHOOL/PATHOL-LAB MED/ANAT PATH

Employment Class:

Academic Staff-Renewable

Job Number:

The university of wisconsin-madison is an equal opportunity and affirmative action employer..

You will be redirected to the application to launch your career momentarily. Thank you!

Frequently Asked Questions

Applicant Tutorial

Disability Accommodations

Pay Transparency Policy Statement

Refer a Friend

You've sent this job to a friend!

Website feedback, questions or accessibility issues: [email protected] .

Learn more about accessibility at UW–Madison .

© 2016–2024 Board of Regents of the University of Wisconsin System • Privacy Statement